Related references
Note: Only part of the references are listed.SARS-CoV-2 M-pro inhibitors: identification of anti-SARS-CoV-2 M-pro compounds from FDA approved drugs
Shiv Bharadwaj et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
Sukanth Kumar Enmozhi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Renin Angiotensin System (RAS) and COVID-19 On the Prescription of RAS Blockers
Reinhold Kreutz et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2020)
Structural changes induced by substitution of amino acid 129 in the coat protein of Cucumber mosaic virus
Vijay Kumar Bhardwaj et al.
GENOMICS (2020)
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
Catrin Sohrabi et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Renin-Angiotensin System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
A. H. Jan Danser et al.
HYPERTENSION (2020)
Natural products against renin-angiotensin system for antifibrosis therapy
Tian Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
MolProbity: More and better reference data for improved all-atom structure validation
Christopher J. Williams et al.
PROTEIN SCIENCE (2018)
MERS-CoV: Understanding the Latest Human Coronavirus Threat
Aasiyah Chafekar et al.
VIRUSES-BASEL (2018)
Flavonoids: promising natural compounds against viral infections
Hovakim Zakaryan et al.
ARCHIVES OF VIROLOGY (2017)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0
Alpeshkumar K. Malde et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Fast and Accurate Predictions of Binding Free Energies Using MM-PBSA and MM-GBSA
Giulio Rastelli et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
Shutoku Matsuyama et al.
JOURNAL OF VIROLOGY (2010)
Ligand affinities predicted with the MM/PBSA method:: Dependence on the simulation method and the force field
Aaron Weis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K
P Mark et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
